San Francisco Business TimesHCP’s Shore at Sierra Point project in South San Francisco recently landed heart drug developer MyoKardia Inc. (NASDAQ: MYOK) and another tenant to fill out the initial 222,000-square-foot phase ahead of schedule, for example, and BioMed’s Gateway of … …read more Source:: San Francisco Real Estate News From Google News
This post first appeared on Zennie62 YouTube News Blog Vlog - Zennie Abraham -, please read the originial post: here
